Open AccessThe effect of selective tyrosine kinase inhibitors on the expression of HIF1α and mTOR in p16-positive and -negative squamous cell carcinoma (HNSCC)
Author(s) -
Benedikt Kramer,
B Kuhlin,
Nicole Rotter,
Christoph Aderhold
Publication year - 2018
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0038-1640071
Subject(s) - erlotinib , gefitinib , nilotinib , cancer research , dasatinib , tyrosine kinase , pi3k/akt/mtor pathway , medicine , basal cell , angiogenesis , tyrosine kinase inhibitor , oncology , chemistry , cancer , epidermal growth factor receptor , signal transduction , receptor , biochemistry